Header Logo

Connection

Doris Benbrook to Receptor, Fibroblast Growth Factor, Type 2

Back to Details
This is a "connection" page, showing publications Doris Benbrook has written about Receptor, Fibroblast Growth Factor, Type 2.
Doris Benbrook
Connection Strength
0.030
Receptor, Fibroblast Growth Factor, Type 2
  1. A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2014 Oct; 135(1):38-43.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.